Trump claims world’s lowest drug prices. TrumpRx discounts a ‘mixed bag,’ report shows.

Key Points:

• The TrumpRx program offers discounted prices on certain brand-name drugs, but a Kaiser Family Foundation (KFF) analysis found mixed results when comparing these prices to those in 11 other wealthy countries; only 5 of 32 drugs were the lowest-priced in the U.S., while 13 were the highest-priced.
• Some drugs like Ozempic and Enbrel remain significantly more expensive in the U.S. through TrumpRx compared to international prices, while others, such as Rydapt, are cheaper through TrumpRx than in countries like France.
• TrumpRx relies on voluntary agreements with drugmakers to offer discounts directly to consumers, a different approach from Biden’s Medicare negotiation strategy, but these discounts often do not apply to insured patients and do not count toward insurance copays or deductibles.
• Price comparisons are complicated by differences in drug availability, confidential discounts abroad, and the limited scope of drugs analyzed, with experts cautioning that while TrumpRx may bring some savings, it has not consistently delivered the lowest global prices as promised.
• Health policy experts warn that as more manufacturers participate, international prices may rise, potentially narrowing savings for Americans without significantly lowering U.S. drug costs over time.